Latest Breaking News On - Analyst recommendations for jazz pharmaceuticals - Page 6 : comparemela.com

Needham & Company LLC Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Needham & Company LLC restated their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $220.00 target price on the specialty pharmaceutical company’s stock. JAZZ has been the subject of several other reports. Barclays reduced their price […]

Los angelesUnited statesPhilipl johnsonPatricia carrInsider transactions at jazz pharmaceuticalsNews ratings for jazz pharmaceuticals dailyThompson siegel walmsleyAnalyst recommendations for jazz pharmaceuticalsLos angeles capital managementJazz pharmaceuticals company profileNeedham companyRoyal bankBlackrock incCantor fitzgeraldInstitutional investors weigh in on jazz pharmaceuticalsSecurities exchange commission

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Buy Rating from Needham & Company LLC

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Buy Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesPatricia carrStifel nicolausPhilipl johnsonJazz pharmaceuticalsNeedham companyNews ratings for jazz pharmaceuticals dailyLos angeles capital managementJazz pharmaceuticals stock downCantor fitzgeraldAnalyst recommendations for jazz pharmaceuticalsJazz pharmaceuticals company profileInstitutional trading of jazz pharmaceuticalsEnvestnet asset management incInsider transactions at jazz pharmaceuticals

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Lowered to $220 00 at Needham & Company LLC

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Lowered to $220 00 at Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesRobertw bairdMark douglas smithInsider transactions at jazz pharmaceuticalsNews ratings for jazz pharmaceuticals dailyJazz pharmaceuticals company profileAnalyst recommendations for jazz pharmaceuticalsJazz pharmaceuticals price performancePacer advisors incNeedham companyLos angeles capital managementEnvestnet asset management incJazz pharmaceuticalsArmistice capitalRoyal bank

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Cut to $170 00 by Analysts at JPMorgan Chase & Co

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Cut to $170 00 by Analysts at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdMark douglas smithJazz pharmaceuticals trading downJpmorgan chase coNews ratings for jazz pharmaceuticals dailyVirtu financialSquare quantitative managementInsider activity at jazz pharmaceuticalsJazz pharmaceuticals company profileNeedham companyCapital partnersRoyal bankPricet rowe associates incAnalyst recommendations for jazz pharmaceuticalsJazz pharmaceuticals

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Cut to $170 00 by Analysts at JPMorgan Chase & Co

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by JPMorgan Chase & Co. from $180.00 to $170.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […]

United statesMark douglas smithRobertw bairdJazz pharmaceuticals company profileInsider activity at jazz pharmaceuticalsNeedham companySquare quantitative managementNews ratings for jazz pharmaceuticals dailyVirtu financialJazz pharmaceuticals trading downJpmorgan chase coJazz pharmaceuticalsAnalyst recommendations for jazz pharmaceuticalsPricet rowe associates incRoyal bankCapital partners